Renal cell carcinoma guideline.
OBJECTIVE
The European Association of Urology (EAU) Guideline Group for renal cell carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice.


METHODS
The recommendations provided in the current guideline are based on a systematic literature search using MedLine, the Cochrane Central Register of Controlled Trials, and publications and review articles.


RESULTS
A limited number of prospective randomised studies are available with high-level evidence. Most publications concerning RCC are based on retrospective analyses, including some larger multicentre validation studies and well-designed controlled studies.


CONCLUSIONS
It must be stressed that the current guideline contains information for the treatment of an individual patient according to a standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC.
Ljungberg
Börje
B
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden, and Department of Urology, Lister Hospital, Stevenage, UK. borje.ljungberg@urologi.umu.se
Hanbury
Damian C
DC
Kuczyk
Marcus A
MA
Merseburger
Axel S
AS
Mulders
Peter F A
PF
Patard
Jean-Jacques
JJ
Sinescu
Ioanel C
IC
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D010535:Laparoscopy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009399:Nephrons; D011379:Prognosis